BIT
LAB icon

BlackRock Institutional Trust’s Standard BioTools LAB Stock Holding History

BlackRock Institutional Trust’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.83M Sell
800,768
-5,458
-0.7% -$34.3K ﹤0.01% 2665
2016
Q3 		$6.46M Buy
806,226
+8,621
+1% +$79.2K ﹤0.01% 2587
2016
Q2 		$7.2M Sell
797,605
-8,432
-1% -$79.3K ﹤0.01% 2490
2016
Q1 		$6.5M Buy
806,037
+957
+0.1% +$6.9K ﹤0.01% 2527
2015
Q4 		$8.7M Buy
805,080
+71,810
+10% +$705K ﹤0.01% 2417
2015
Q3 		$5.95M Buy
733,270
+130,782
+22% +$2.06M ﹤0.01% 2618
2015
Q2 		$14.6M Buy
602,488
+59,813
+11% +$1.89M ﹤0.01% 2142
2015
Q1 		$22.8M Buy
542,675
+154,837
+40% +$6.12M ﹤0.01% 1845
2014
Q4 		$13.1M Buy
387,838
+62,365
+19% +$1.77M ﹤0.01% 2196
2014
Q3 		$7.97M Sell
325,473
-19,454
-6% -$547K ﹤0.01% 2463
2014
Q2 		$10.1M Sell
344,927
-93,560
-21% -$3M ﹤0.01% 2431
2014
Q1 		$19.3M Buy
438,487
+130,020
+42% +$5.72M ﹤0.01% 1987
2013
Q4 		$11.8M Sell
308,467
-19,210
-6% -$566K ﹤0.01% 2304
2013
Q3 		$7.19M Buy
327,677
+3,519
+1% +$69.1K ﹤0.01% 2541
2013
Q2 		$5.66M Buy
+324,158
New +$5.69M ﹤0.01% 2635

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock Institutional Trust's LAB Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Standard BioTools (LAB) stake by 0.68% in Q4 2016, selling an estimated $34.3K and leaving 800,768 shares worth $5.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2665.

BlackRock Institutional Trust first reported a position in LAB in Q2 2013 and has held it in 15 quarters since. The position peaked at $22.8M in Q1 2015. 83 funds tracked by Wall St. Rank hold LAB as of Q4 2016.

  • BlackRock Institutional Trust held 800,768 shares of Standard BioTools worth $5.83M as of Q4 2016.
  • BlackRock Institutional Trust sold 5,458 Standard BioTools shares in Q4 2016, an estimated $34.3K.
  • Standard BioTools made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2665 holding.
  • BlackRock Institutional Trust first reported a position in Standard BioTools in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Standard BioTools position peaked at $22.8M in Q1 2015.
  • 83 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.